Skopko Chest Congestion Relief Pe
NDC Package 37012-077-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Skopko Chest Congestion Relief Pe is ■ adults and children 12 years and over:take 1 caplet every 4 hours as needed■ children 6 to under 12 years:take 1/2 caplet every 4 hours as needed■ children under 6 years: consult a doctorDo not exceed 6 doses in a 24 hour period or as directed by a doctor. Marketed by Shopko, this product is identified by NDC 37012-077 and is authorized under FDA application part341.

Identification & Billing

NDC Package Code
37012-077-01
Package Description
1 BOTTLE, PLASTIC in 1 CARTON / 50 TABLET in 1 BOTTLE, PLASTIC (37012-077-50)
Product Code
37012-077
11-Digit Billing Format
37012007701
RxNorm Crosswalk
  • RxCUI: 1304111 - guaiFENesin 400 MG / phenylephrine HCl 10 MG Oral Tablet
  • RxCUI: 1304111 - guaifenesin 400 MG / phenylephrine hydrochloride 10 MG Oral Tablet

Clinical Specifications

Proprietary Name
Skopko Chest Congestion Relief Pe PE
Dosage Form
-
Usage Information
■ adults and children 12 years and over:take 1 caplet every 4 hours as needed■ children 6 to under 12 years:take 1/2 caplet every 4 hours as needed■ children under 6 years: consult a doctorDo not exceed 6 doses in a 24 hour period or as directed by a doctor.

Regulatory & Marketing

Labeler Name
Shopko
FDA Application #
part341
Marketing Category
OTC MONOGRAPH FINAL - A product marketed pursuant to a final Over-the-Counter (OTC) Drug Monograph.
Start Marketing Date
06-05-2006
Listing Expiration
12-31-2019
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 37012-077-01 identifies a specific commercial package of 1 bottle, plastic in 1 carton / 50 tablet in 1 bottle, plastic (37012-077-50) of Skopko Chest Congestion Relief Pe PE, labeled by Shopko. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Shopko on June 05, 2006. The current certification is valid through December 31, 2019.

How is this Shopko product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 37012007701. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
37012-077-01
11-Digit CMS (5-4-2)
37012-0077-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.